These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 9121960
1. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: a new form of proarrhythmia. Vlay LC, Vlay SC. Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):132-3. PubMed ID: 9121960 [Abstract] [Full Text] [Related]
2. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator. Fetter JG, Stanton MS, Benditt DG, Trusty J, Collins J. Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174 [Abstract] [Full Text] [Related]
4. Implantable transvenous cardioverter-defibrillators. Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D. Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144 [Abstract] [Full Text] [Related]
5. [The progress of electrical treatment of arrhythmia]. Fang ZX. Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Jan; 26(1):3-6. PubMed ID: 16104147 [Abstract] [Full Text] [Related]
6. The value of DDD pacing in patients with an implantable cardioverter defibrillator. Geelen P, Lorga Filho A, Chauvin M, Wellens F, Brugada P. Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):177-81. PubMed ID: 9121985 [Abstract] [Full Text] [Related]
8. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ. Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [Abstract] [Full Text] [Related]
9. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation]. Siebels J, Schneider MA, Kuck KH. Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289 [Abstract] [Full Text] [Related]
10. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
11. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group. Neuzner J. Pacing Clin Electrophysiol; 1994 Jul 08; 17(7):1243-55. PubMed ID: 7937230 [Abstract] [Full Text] [Related]
12. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators. Kleiman RB, Callans DJ, Hook BG, Marchlinski FE. Pacing Clin Electrophysiol; 1994 Sep 08; 17(9):1462-8. PubMed ID: 7991416 [Abstract] [Full Text] [Related]
13. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Schmitt C, Montero M, Melichercik J. Pacing Clin Electrophysiol; 1994 Mar 08; 17(3 Pt 1):295-302. PubMed ID: 7513854 [Abstract] [Full Text] [Related]
14. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH, Yee R, Jung W. J Am Coll Cardiol; 1996 Aug 08; 28(2):400-10. PubMed ID: 8800117 [Abstract] [Full Text] [Related]
15. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF. Circulation; 1995 Apr 15; 91(8):2204-13. PubMed ID: 7697850 [Abstract] [Full Text] [Related]
16. The role of cardioversion therapy in patients with implanted cardioverter defibrillators. Nathan AW. Am Heart J; 1994 Apr 15; 127(4 Pt 2):1046-51. PubMed ID: 8160579 [Abstract] [Full Text] [Related]
17. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival. Bhatia A, Cooley R, Berger M, Blanck Z, Dhala A, Sra J, Axtell-Mcbride K, Vandervort C, Akhtar M. Curr Probl Cardiol; 2004 Jun 15; 29(6):303-56. PubMed ID: 15159713 [Abstract] [Full Text] [Related]
18. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Serafrica M, Sosa Liprandi A. Pacing Clin Electrophysiol; 1995 Jan 15; 18(1 Pt 2):133-6. PubMed ID: 7724386 [Abstract] [Full Text] [Related]
19. Ventricular fibrillation triggered by a pacemaker-mediated tachycardia protection algorithm. Galand V, Behar N, Martins RP. Europace; 2017 Aug 01; 19(8):1342. PubMed ID: 28444182 [No Abstract] [Full Text] [Related]